ASKARA - For three decades, Siloam Hospitals Lippo Village has continuously advanced its oncology program to meet the growing complexity of cancer care. Building on three decades of trusted clinical excellence, the hospital remains committed to shaping the future of oncology through precision medicine, multidisciplinary collaboration, advanced technology, and access to internationally recognized expertise.

As cancer care becomes increasingly complex, optimal treatment extends beyond individual expertise. It requires coordinated collaboration across multiple specialties to ensure that every clinical decision is informed by the most comprehensive assessment possible. Recognizing this shift, Siloam Hospitals Lippo Village continues to strengthen its oncology ecosystem through integrated clinical pathways, advanced diagnostic capabilities, and collaborative care models that align with international standards.

A cornerstone of this approach is the hospital's Multidisciplinary Team (MDT), where specialists from medical oncology, surgical oncology, radiation oncology, radiology, pathology, nuclear medicine, and other relevant specialties collaborate to review each patient's case collectively. Through evidence-based discussions and consensus-driven treatment planning, MDT enables individualized care strategies that address not only the disease but also each patient's unique clinical profile and treatment goals.

Complementing this collaborative care model, Siloam Hospitals Lippo Village offers a dedicated Second Opinion Service designed to provide patients with greater clarity and confidence in their treatment journey. Through a comprehensive review of diagnosis, disease staging, pathology, imaging findings, and available treatment options, the service empowers patients to make well-informed decisions while ensuring access to expert multidisciplinary perspectives before initiating or modifying their treatment plan.

The participation of Michael Flynn, MD, PhD (Consultant Medical Oncologist and Associate Professor at University College London Hospital, United Kingdom) reflects Siloam Hospitals Lippo Village's ongoing commitment to strengthening international collaboration and advancing the exchange of clinical knowledge with leading oncology institutions worldwide. Through meaningful dialogue and shared expertise, the forum reinforces the hospital's vision of continuously advancing oncology practice while expanding access to internationally recognized standards of care in Indonesia.

"Advances in oncology are happening at an unprecedented pace, but meaningful progress depends on collaboration. Bringing together specialists across disciplines, supported by accurate diagnostics and evidence-based decision making, allows us to deliver more personalized and effective treatment for every patient. It is a privilege to collaborate with Siloam Hospitals Lippo Village, whose commitment to multidisciplinary care, continuous innovation, and international knowledge exchange reflects the direction modern cancer care should take," said Michael Flynn, MD, PhD, Consultant Medical Oncologist and Associate Professor at University College London Hospital, United Kingdom.

"Modern oncology is no longer defined by individual expertise alone. The best outcomes are achieved through multidisciplinary collaboration, scientific innovation, and continuous knowledge exchange. As we look beyond 30 years of trusted service, our commitment is to continue building an oncology program that not only embraces the latest advances in cancer treatment but also delivers truly personalized, evidence-based care for every patient," said dr. Suyanto, Sp.PD, MRCP Oncology (UK), Medical Oncologist at Siloam Hospitals Lippo Village.

Guided by the vision of "From Three Decades of Trusted Care to the Future of Oncology," Siloam Hospitals Lippo Village reaffirms its commitment to shaping the next generation of cancer care. Building on 30 years of trusted service, the hospital will continue to advance oncology through innovation, international collaboration, and a steadfast commitment to delivering personalized, integrated, and future-ready care for every patient.